Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19 (INSPIRATION)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04486508
Recruitment Status : Active, not recruiting
First Posted : July 24, 2020
Last Update Posted : April 19, 2021
Sponsor:
Collaborators:
Brigham and Women's Hospital
Tehran Heart Center
Masih Daneshvari Hospital
Hazrat Rasool Hospital
Modarres Hospital
Firuzgar hospital affiliated to Iran University of Medical Sciences
Imam Khomeini Hospital
Sina Hospital, Iran
Tabriz University of Medical Sciences
Shariati Hospital
Imam Ali Hospital
Labbafinejhad Hospital
Information provided by (Responsible Party):
Parham Sadeghipour, Rajaie Cardiovascular Medical and Research Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : April 4, 2021
Estimated Study Completion Date : May 3, 2021
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):